214 related articles for article (PubMed ID: 19378293)
1. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.
Calleri E; Temporini C; Caccialanza G; Massolini G
ChemMedChem; 2009 Jun; 4(6):905-16. PubMed ID: 19378293
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
[TBL] [Abstract][Full Text] [Related]
3. Applications of mass spectrometry in early stages of target based drug discovery.
Deng G; Sanyal G
J Pharm Biomed Anal; 2006 Feb; 40(3):528-38. PubMed ID: 16256286
[TBL] [Abstract][Full Text] [Related]
4. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
Slon-Usakiewicz JJ; Ng W; Foster JE; Dai JR; Deretey E; Toledo-Sherman L; Redden PR; Pasternak A; Reid N
J Med Chem; 2004 Oct; 47(21):5094-100. PubMed ID: 15456253
[TBL] [Abstract][Full Text] [Related]
5. Frontal affinity chromatography coupled to mass spectrometry for screening mixtures of enzyme inhibitors.
Zhang B; Palcic MM; Schriemer DC; Alvarez-Manilla G; Pierce M; Hindsgaul O
Anal Biochem; 2001 Dec; 299(2):173-82. PubMed ID: 11730340
[TBL] [Abstract][Full Text] [Related]
6. Frontal affinity chromatography-mass spectrometry.
Ng ES; Chan NW; Lewis DF; Hindsgaul O; Schriemer DC
Nat Protoc; 2007; 2(8):1907-17. PubMed ID: 17703202
[TBL] [Abstract][Full Text] [Related]
7. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE
Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
[TBL] [Abstract][Full Text] [Related]
8. Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.
Slon-Usakiewicz JJ; Ng W; Dai JR; Pasternak A; Redden PR
Drug Discov Today; 2005 Mar; 10(6):409-16. PubMed ID: 15808820
[TBL] [Abstract][Full Text] [Related]
9. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS).
Ng W; Dai JR; Slon-Usakiewicz JJ; Redden PR; Pasternak A; Reid N
J Biomol Screen; 2007 Mar; 12(2):167-74. PubMed ID: 17218664
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry.
Kosaka T; Okuyama R; Sun W; Ogata T; Harada J; Araki K; Izumi M; Yoshida T; Okuno A; Fujiwara T; Ohsumi J; Ichikawa K
Anal Chem; 2005 Apr; 77(7):2050-5. PubMed ID: 15801737
[TBL] [Abstract][Full Text] [Related]
11. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
Wabnitz PA; Loo JA
Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
[TBL] [Abstract][Full Text] [Related]
12. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
Katayama H; Oda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
[TBL] [Abstract][Full Text] [Related]
13. Frontal affinity chromatography combined on-line with mass spectrometry: a tool for the binding study of different epidermal growth factor receptor inhibitors.
Zhu L; Chen L; Luo H; Xu X
Anal Chem; 2003 Dec; 75(23):6388-93. PubMed ID: 14640705
[TBL] [Abstract][Full Text] [Related]
14. Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection.
Temporini C; Pochetti G; Fracchiolla G; Piemontese L; Montanari R; Moaddel R; Laghezza A; Altieri F; Cervoni L; Ubiali D; Prada E; Loiodice F; Massolini G; Calleri E
J Chromatogr A; 2013 Apr; 1284():36-43. PubMed ID: 23466198
[TBL] [Abstract][Full Text] [Related]
15. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry.
Temporini C; Ceruti S; Calleri E; Ferrario S; Moaddel R; Abbracchio MP; Massolini G
Anal Biochem; 2009 Jan; 384(1):123-9. PubMed ID: 18835238
[TBL] [Abstract][Full Text] [Related]
16. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
Toledo-Sherman L; Deretey E; Slon-Usakiewicz JJ; Ng W; Dai JR; Foster JE; Redden PR; Uger MD; Liao LC; Pasternak A; Reid N
J Med Chem; 2005 May; 48(9):3221-30. PubMed ID: 15857128
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
Tolonen A; Turpeinen M; Pelkonen O
Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
[TBL] [Abstract][Full Text] [Related]
18. Method for quantitative protein-ligand affinity measurements in compound mixtures.
Annis DA; Shipps GW; Deng Y; Popovici-Müller J; Siddiqui MA; Curran PJ; Gowen M; Windsor WT
Anal Chem; 2007 Jun; 79(12):4538-42. PubMed ID: 17500537
[TBL] [Abstract][Full Text] [Related]
19. Evaluating carbohydrate-protein binding interactions using frontal affinity chromatography coupled to mass spectrometry.
Palcic MM; Zhang B; Qian X; Rempel B; Hindsgaul O
Methods Enzymol; 2003; 362():369-76. PubMed ID: 12968377
[No Abstract] [Full Text] [Related]
20. Biochemical applications of mass spectrometry in pharmaceutical drug discovery.
Geoghegan KF; Kelly MA
Mass Spectrom Rev; 2005; 24(3):347-66. PubMed ID: 15389851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
